eli lilly glp 1 oral Gets Speedy FDA Nod for GLP-1 Drug, a Competitor to New Novo Nordisk Pill A new oral GLP-1 medication

Reuben A, Tillman H, Fontana RJ, Davern T, McGuire B, Stravitz RT, Durkalski V, Larson AM, Liou I, Fix O, Schilsky M, McCashland T, Hay JE, Murray N, Shaikh OS, Ganger D, Zaman A, Han SB, Chung RT, Smith A, Brown R, Crippin J, Harrison ME, Koch D, Munoz S, Reddy KR, Rossaro L, Satyanarayana R, Hassanein T, Hanje AJ, Olson J, Subramanian R, Karvellas C, Hameed B, Sherker AH, Robuck P, Lee WM

However, injectable B12 has different pharmacokinetics than dietary B12

doi: 10.1038/s41584-022-00749-9 15 XiangJYangXTanMGuoJYeYDengJet al

2016 Apr;6(2)

Osteoarthritis and Cartilage, 27, S280-S282

100 This randomized placebo-controlled trial included 5380 patients and had a median follow-up of 18 months